Fang et al. investigated whether IL-6/STAT3-mediated hepatic autophagosome activation and hepatocyte oxygen consumption contribute to NAFLD hepatoprotection. Here, STAT3 is linked to metabolic dysfunction-associated steatotic liver disease.